SMAD4 and cancer: Next-generation sequencing (NGS) analysis using a panel of 25 hereditary cancer-related genes performed on the index case’s DNA identified a heterozygous variant in SMAD4 intron 2 (NM_005359.6: c.424+5G>A) (Figure 2A), which was confirmed by Sanger sequencing (Figure 2B).